Mean age Mean±SD |
63.89±6.08 |
Pre-operative Total PSA (ng/dl) n (%) |
|
0-10 |
188 (72.6%) |
11-20 |
56 (21.6%) |
>20 |
15 (5.8%) |
Clinical stage n (%) |
|
T1c- T2a |
219 (84.6%) |
T2b |
27 (10.4%) |
T2c |
13 (5.0%) |
Total core number Median (min-max) |
12 (6-30) |
Positive core percentage Mean |
33,77% |
Pre-operative biopsy score n (%) |
|
GS 3+3 |
186 (71.8%) |
GS 3+4 |
45 (17.3%) |
GS 4+3 |
16 (6.2%) |
GS 4+4 |
8 (3.1%) |
GS 3+5 |
3 (1.2%) |
GS 4+5 |
1 (0.4%) |
Biochemical recurrence n(%) |
|
Yes |
52 (20.1%) |
No |
207 (79.9%) |
Follow-up time (month) Median (min-max) |
60.0
(6.0-148.0) |
BCR time (month) Median (min-max) |
12.0 (3.0-48.0) |